{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T21:32:42Z","timestamp":1782768762471,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671076"],"award-info":[{"award-number":["31671076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200872"],"award-info":[{"award-number":["81200872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.neulet.2021.136291","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T22:04:23Z","timestamp":1634594663000},"page":"136291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice"],"prefix":"10.1016","volume":"765","author":[{"given":"Kang","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2021.136291_b0005","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2021.136291_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00357","article-title":"Orexin system: the key for a healthy life","volume":"8","author":"Chieffi","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.neulet.2021.136291_b0015","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neulet.2021.136291_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00835","article-title":"Orexin-A exerts neuroprotective effects via OX1R in Parkinson's disease","volume":"12","author":"Liu","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neulet.2021.136291_b0025","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2021.136291_b0030","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.1007\/s12035-019-01682-x","article-title":"Early sociability and social memory impairment in the A53T mouse model of Parkinson's disease are ameliorated by chemogenetic modulation of orexin neuron activity","volume":"56","author":"Stanojlovic","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neulet.2021.136291_b0035","doi-asserted-by":"crossref","first-page":"104754","DOI":"10.1016\/j.neuint.2020.104754","article-title":"Orexin-and Parkinson's disease: a protective neuropeptide with therapeutic potential","volume":"138","author":"Liu","year":"2020","journal-title":"Neurochem Int"},{"key":"10.1016\/j.neulet.2021.136291_b0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neulet.2014.07.014","article-title":"Neuroprotection by Orexin-A via HIF-1alpha induction in a cellular model of Parkinson's disease","volume":"579","author":"Feng","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neulet.2021.136291_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/rej.2016.1836","article-title":"Orexin-A protects human neuroblastoma SH-SY5Y cells against 6-hydroxydopamine-induced neurotoxicity: involvement of PKC and PI3K signaling pathways","volume":"20","author":"Pasban-Aliabadi","year":"2017","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.neulet.2021.136291_b0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/01616412.2017.1352185","article-title":"The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson's disease","volume":"39","author":"Hadadianpour","year":"2017","journal-title":"Neurol Res"},{"key":"10.1016\/j.neulet.2021.136291_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/mol.114.095703","article-title":"The sleep-modulating peptide orexin-B protects midbrain dopamine neurons from degeneration, alone or in cooperation with nicotine","volume":"87","author":"Guerreiro","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neulet.2021.136291_b0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jnc.14568","article-title":"Orexins increase the firing activity of nigral dopaminergic neurons and participate in motor control in rats","volume":"147","author":"Liu","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.neulet.2021.136291_b0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5607\/en.2017.26.2.97","article-title":"Optogenetic rescue of locomotor dysfunction and dopaminergic degeneration caused by alpha-synuclein and EKO genes","volume":"26","author":"Qi","year":"2017","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.neulet.2021.136291_b0070","article-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2004","journal-title":"Gulf professional publishing"},{"key":"10.1016\/j.neulet.2021.136291_b0075","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1096\/fj.10-173625","article-title":"Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease","volume":"25","author":"Good","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.neulet.2021.136291_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4077\/CJP.2011.AMM014","article-title":"Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons","volume":"54","author":"Gui","year":"2011","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.neulet.2021.136291_b0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12311-009-0146-0","article-title":"Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro","volume":"9","author":"Yu","year":"2010","journal-title":"Cerebellum"},{"key":"10.1016\/j.neulet.2021.136291_b0090","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1152\/jn.2001.85.5.2008","article-title":"Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area","volume":"85","author":"Kiyashchenko","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neulet.2021.136291_b0095","doi-asserted-by":"crossref","first-page":"C800","DOI":"10.1152\/ajpcell.00125.2019","article-title":"Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson's disease","volume":"317","author":"Wang","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.neulet.2021.136291_b0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000069507","article-title":"Orexin-B augments voltage-gated L-type Ca(2+) current via protein kinase C-mediated signalling pathway in ovine somatotropes","volume":"77","author":"Xu","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neulet.2021.136291_b0105","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1096\/fj.12-220418","article-title":"Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease","volume":"27","author":"Michel","year":"2013","journal-title":"FASEB J"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394021006704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:11:09Z","timestamp":1778685069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394021006704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":21,"alternative-id":["S0304394021006704"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136291","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2021.136291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"136291"}}